Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities-Reference-Cited by-同舟云学术

Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities

Published:2023-10 Issue: Volume:190 Page:104109
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Zattarin Emma,Taglialatela Ida,Lobefaro Riccardo,Leporati Rita,Fucà Giovanni,Ligorio Francesca,Sposetti Caterina,Provenzano Leonardo,Azzollini Jacopo,Vingiani Andrea,Ferraris Cristina,Martelli Gabriele,Manoukian Siranoush,Pruneri Giancarlo,de Braud Filippo,Vernieri Claudio

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference109 articles.

1. Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis;van den Broek;PLoS One,2015

2. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex;Brzovic;Nat. Struct. Biol.,2001

3. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer;Clapperton;Nat. Struct. Mol. Biol.,2004

4. Structure-function of the tumor suppressor BRCA1;Clark;Comput. Struct. Biotechnol. J.,2012

5. A real-world evidence study of CDK4/6 inhibitor treatment patterns and outcomes in metastatic breast cancer by germline BRCA mutation status;Collins;Oncol. Ther.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis;Therapeutic Advances in Medical Oncology;2024-01

2. Introduction to Neoplasia;Reference Module in Biomedical Sciences;2024